PR NEWSWIRE - Contenuti promozionali

immediapress comunicato stampa

Ribo Submits European Clinical Trial Application for a Novel Dual Targeting siRNA SR122 for Mixed and Severe Dyslipidemia, Further Strengthening Its Footprint in the Area of Lipid Disorder

SUZHOU, China and MÖLNDAL, Sweden, Nov. 10, 2026 /PRNewswire/ -- Suzhou Ribo Life Science (06938.HK) and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo") announced the submission of a Phase Ⅰ Clinical Trial Application (CTA) in EU for SR122, a dual GalNAc conjugated siR...

immediapress comunicato stampa

Hyland Makes Partnership Payoff with New Referral Program

CLEVELAND, Nov. 9, 2026 /PRNewswire/ -- Hyland, a global leader in driving enterprise scale content intelligence and automation, today announced the launch of the Hyland Referral Partner Program, a new way for organizations to partner with Hyland and get paid for the new business they help the compan...



SEGUICI SUI SOCIAL

threads whatsapp linkedin twitter youtube facebook instagram

ora in
Prima pagina
articoli
in Evidenza